Evaluating video-based consultations in routine clinical practice at a comprehensive cancer center.


Journal

Acta oncologica (Stockholm, Sweden)
ISSN: 1651-226X
Titre abrégé: Acta Oncol
Pays: England
ID NLM: 8709065

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 27 11 2023
pubmed: 10 11 2023
entrez: 10 11 2023
Statut: ppublish

Résumé

Integrating telemedicine into cancer care remains a major challenge. There are little clinical evidence for teleconsultation efficacy and safety in daily oncology practice. This study as a pioneering experience, aimed to analyze patient and physician opinions regarding the implementation of telemedicine consultations, and to identify major limitations of telehealth spread in an oncology institute. During COVID-19 lockdown, patients and physicians who took part to at least one video-based teleconsultation between March and May 2020, were enrolled in this observational study. All eligible patients received an anonymous online questionnaire. On the other hand, all physicians eligible to participate were asked through email to complete a questionnaire. In this study, 31 physicians and 304 patients consented to participate in this study by answering the questionnaire and were included. Regarding telemedicine satisfaction, 65.8% of patients were satisfied. The lack of clinical examination was the major limitation reported by 77% of patients. Patients belonging to a high socio-professional category were statistically more dissatisfied with the relationship with their doctor (OR = 2.31 and 95% CI [1.12; 4.74]). This study showed promising results of incorporating video-based teleconsultations into cancer patient management. Randomized clinical trials are needed in order to accelerate the digital implementation in clinical practice.

Identifiants

pubmed: 37948066
doi: 10.1080/0284186X.2023.2278758
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1905-1912

Auteurs

Thibaut Mottet (T)

Department of Medical Oncology, Institut Bergonié, Bordeaux, France.

Victor Hémar (V)

Department of Internal Medicine and Infectious Diseases, Hôpital Saint-André, Bordeaux, France.

Sylvia Enfedaque (S)

Department of Quality and Risk Management, Institut Bergonié, Bordeaux, France.

Simone Mathoulin-Pélissier (S)

Department of Biostatistics and Epidemiology, Institut Bergonié, Bordeaux, France.

Hélène Charitansky (H)

Department of Surgery, Institut Bergonié, Bordeaux, France.

Yann Godbert (Y)

Department of Nuclear Medicine, Institut Bergonié, Bordeaux, France.

Guilhem Roubaud (G)

Department of Medical Oncology, Institut Bergonié, Bordeaux, France.

Mathilde Cabart (M)

Department of Medical Oncology, Institut Bergonié, Bordeaux, France.

Camille Chakiba (C)

Department of Medical Oncology, Institut Bergonié, Bordeaux, France.

François Chomy (F)

Department of Medical Oncology, Institut Bergonié, Bordeaux, France.

Laura Haik (L)

Department of Medical Oncology, Institut Bergonié, Bordeaux, France.

Nicolas Le Dantec (N)

Information Department Service, Institut Bergonié, Bordeaux, France.

Wafa Bouleftour (W)

Department of Medical Oncology, CHU Saint Etienne, Saint-Etienne, France.

Nicolas Magné (N)

Department of Radiation Oncology, Institut Bergonié, Bordeaux, France.

Nathalie Quenel Tueux (N)

Department of Medical Oncology, Institut Bergonié, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH